fda bans compounded semaglutide and tirzepatide Ends GLP-1s: What to Know FDA Says Compounded Tirzepatide Must

The weight effect comes from several directions at once

While individual GLP-1 receptor agonists may vary in their specific applications (some are approved primarily for diabetes, others for chronic weight management), their core mechanism of action offers a powerful approach to supporting weight loss efforts

Zepbound (KwikPen) Activates both GLP-1 and GIP receptors, the two gut hormones that signal appetite and satiety

Fiber, Hydration, and Micronutrients Matter Macros are the foundation, but they aren't the whole diet

For uninsured patients or those with high deductibles, compounded GLP-1 provides immediate, affordable access to evidence-based weight loss treatment